|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||0.0762 - 0.0762|
|52 Week Range||0.0513 - 0.0793|
|Beta (5Y Monthly)||1.16|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for QPTFF
Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") today announced the sale of its share ownership interest in Bioceltran Co., Ltd. ("Bioceltran") to Dr. Sang Ho Jang, founder of Bioceltran, for sale proceeds of $300,0000 and the termination and return of the Photodynamic Therapy ("PDT") technology license. Bioceltran is a private, Korea based company developing skin penetrating active molecules for cosmetic and pharmaceutical use.
Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") today announced the results of its July 19, 2022 annual general meeting of shareholders.
Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") announces that it has borrowed $1 million of working capital funding from one of its investee companies, OncoQuest Inc.